Andrew Welch

Andrew Welch, DO

Assistant Professor of Clinical

Medical Sciences Building

COM IM Endocrinology Division - 0547

Education

BS: Brigham Young University Provo, UT, 2013 (Neuroscience)

DO: Arizona College of Osteopathic Medicine Glendale, AZ, 2020

Certifications

American Board of Internal Medicine (Endocrinology-Diabetes and Metabolism) (Certification Date: 10-24-2023 )

American Board of Internal Medicine (Certification Date: 08-20-2020 )

Clinical Interests

Diabetes

Endocrinology

Thyroid Cancer

Adrenal Insufficiency

Adrenocortical Adenoma

Cushing syndrome (Hypercortisolism)

Diabetes Mellitus

Diabetes Type 1 (Diabetes Mellitus, Type 1)

Diabetes Type 2 (Diabetes Mellitus, Type 2)

Diabetic Foot

Diabetic Hypoglycemia

Diabetic Ketoacidosis

Diabetic Nephropathy

Diabetic Neuropathies

Hyperparathyroidism

Hyperthyroidism

Hypothyroidism (Underactive thyroid)

Obesity

Osteoporosis

Pituitary Adenoma

Prolactinoma

Specialities

Endocrinology-Diabetes and Metabolism

Internal Medicine

Research Support

Grant: #10769-UC / 3-SRA-2025-1787-M-B Investigators:Welch, Andrew 09-01-2025 -08-31-2028 Breakthrough T1D Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: Multicenter, Registry-based Study Role:PI 11660.00 Hold Level:Non Profit

Publications

Peer Reviewed Publications

Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian  (2023). The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans. The Journal of clinical investigationMore Information

Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian  (2023). Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes. American journal of physiology. Endocrinology and metabolism, 325 (2) , E119-E131More Information

Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian  (2023). The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes, 72 (4) , 449-454More Information

Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh  (2017). Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2). Diabetes, 66 (8) , 2201-2212More Information

Welch, Andrew A; Toro-Tobon, David; Rachmasari, Kharisa N; Sandooja, Rashi B; Rahimi, Leili; Mohan, Sneha; Hewlett, Jennifer R; Clark, Jennifer; Maheshwari, Arvind; Zhang, Catherine; Brito, Juan P  (2024). Improving Intravenous and Subcutaneous Insulin Overlap During Treatment of Diabetic Ketoacidosis: A Quality Improvement Project. Mayo Clinic proceedings. Innovations, quality & outcomes, 8 (3) , 293-300More Information